BIOMAT Database Logo BIOMAT Database Logo

Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors. 2012

Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Merck Research Laboratories, Kenilworth, NJ 07033, USA. frank.bennett@merck.com

Introduction of nitrogen atom into the benzene ring of a previously identified HCV replication (replicase) benzofuran inhibitor 2, resulted in the discovery of the more potent pyridofuran analogue 5. Subsequent introduction of small alkyl and alkoxy ligands into the pyridine ring resulted in further improvements in replicon potency. Replacement of the 4-chloro moiety on the pyrimidine core with a methyl group, and concomitant monoalkylation of the C-2 amino moiety resulted in the identification of several inhibitors with desirable characteristics. Inhibitor 41, from the monosubstituted pyridofuran and inhibitor 50 from the disubstituted series displayed excellent potency, selectivity (GAPDH/MTS CC(50)) and PK parameters in all species studied, while the selectivity in the thymidine incorporation assay (DNA·CC(50)) was low.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran
D012324 RNA-Dependent RNA Polymerase An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293) Nucleoside-Triphosphate:RNA Nucleotidyltransferase (RNA-directed),RNA Replicase,RNA-Dependent RNA Replicase,RNA-Directed RNA Polymerase,RNA Dependent RNA Polymerase,RNA Dependent RNA Replicase,RNA Directed RNA Polymerase,RNA Polymerase, RNA-Dependent,RNA Polymerase, RNA-Directed,RNA Replicase, RNA-Dependent,Replicase, RNA,Replicase, RNA-Dependent RNA

Related Publications

Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Novel substituted pyrimidines as HCV replication (replicase) inhibitors.
January 2012, Bioorganic & medicinal chemistry letters,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Substituted imidazopyridines as potent inhibitors of HCV replication.
May 2009, Journal of hepatology,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
2',4'-Difluoro-2'-methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication.
March 2014, ACS medicinal chemistry letters,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Biological evaluation of 5-substituted pyrimidine derivatives as inhibitors of brassinosteroid biosynthesis.
April 2001, Bioscience, biotechnology, and biochemistry,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Aminoquinoline derivatives as HCV inhibitors.
March 2014, ACS medicinal chemistry letters,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Synthesis of 9-(2-beta-C-methyl-beta-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication.
February 2005, Bioorganic & medicinal chemistry letters,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication.
November 2016, European journal of medicinal chemistry,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Substituted Benzofurans as Inhibitors of HCV NS5B Protein.
March 2014, ACS medicinal chemistry letters,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Identification of pyrimidine derivatives as hSMG-1 inhibitors.
November 2012, Bioorganic & medicinal chemistry letters,
Frank Bennett, and Hollis S Kezar, and Vinay Girijavallabhan, and Yuhua Huang, and Regina Huelgas, and Randall Rossman, and Neng-Yang Shih, and John J Piwinski, and Malcolm MacCoss, and Cecil D Kwong, and Jeremy L Clark, and Anita T Fowler, and Feng Geng, and Abhijit Roychowdhury, and Robert C Reynolds, and Joseph A Maddry, and Subramaniam Ananthan, and John A Secrist, and Cheng Li, and Robert Chase, and Stephanie Curry, and Hsueh-Cheng Huang, and Xiao Tong, and F George Njoroge, and Ashok Arasappan
Fused and Substituted Pyrimidine Derivatives as Profound Anti-Cancer Agents.
January 2021, Anti-cancer agents in medicinal chemistry,
Copied contents to your clipboard!